Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

14 Nov, 2017, 08:30 GMT GENOMICA Receives Authorization for the Commercialization of its Diagnostic Kits and Instruments in South Korea

GENOMICA, a leading molecular diagnostics company belonging to the PharmaMar Group (MCE: PHM), has announced that it has received authorization...


14 Nov, 2017, 08:00 GMT EMA Grants Orphan Drug Designation to Debiopharm International SA's FGFR Inhibitor Debio 1347 in the Treatment of Biliary Tract Cancer

Debiopharm International SA (Debiopharm - http://www.debiopharm.com), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company,...


14 Nov, 2017, 08:00 GMT New Study Demonstrates Significant Clinical Workflow and Staff Experience Benefits of Philips' Azurion Image-guided Therapy Platform

- Two year study* found that clinicians' use of Azurion enabled significant reductions in procedure time, in-lab patient...


13 Nov, 2017, 17:59 GMT Groupe Sebbin Announces the Launch of One of the World's Largest Long Term Prospective Clinical Trials on Silicone Breast Implants

Groupe SEBBIN is a global medical device company with over 30 years experience in the development, manufacture and marketing of medical devices...


13 Nov, 2017, 15:31 GMT SKY92 Gene Signature Facilitates Cost-effective, Risk-stratified Treatment of Multiple Myeloma

SkylineDx announced new data from the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research...


13 Nov, 2017, 13:46 GMT Stryker announces publication of the DAWN™ Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and...


13 Nov, 2017, 13:15 GMT Merck Receives FDA Approval for New GONAL-f® Prefilled Pen

- New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] - Insights of...


13 Nov, 2017, 11:48 GMT LSO Medical to Unveil SnakeBack® Technology at MEDICA 2017

LSO Medical announced today plans to unveil their newly engineered endovenous therapy technology SnakeBack® at the 2017 MEDICA show in Dusseldorf...


13 Nov, 2017, 08:10 GMT GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica

Groundbreaking nucleic acid detection technology using nanomaterials GNA Biosolutions GmbH, a molecular technology company based in Martinsried,...


13 Nov, 2017, 08:00 GMT NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in Preclinical Model

NousCom, an oncology company developing next-generation cancer vaccines based on its Exovax platform, today announced preclinical data of its...


13 Nov, 2017, 08:00 GMT PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer

Life Sciences Leader to Guide Company through its Next Growth Phase and Product Launch in 2018 The Board of Directors of PLAQUETEC LTD...


13 Nov, 2017, 07:00 GMT Audentes Therapeutics Announces MHRA Approval of Clinical Trial Authorisation Application for AT342 to Treat Crigler-Najjar Syndrome

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients...


10 Nov, 2017, 12:12 GMT Zydus Announces Regulatory Approval of Lipaglyn™ (Saroglitazar Magnesium) in Mexico

Approval to commercialize Lipaglyn™ (Saroglitazar Magnesium) in Mexico for treatment of: - Dyslipidemia in patients with diabetes...


09 Nov, 2017, 07:00 GMT Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field

Neurimmune, a global leader in the discovery and development of human-derived monoclonal antibodies, today announced that it has entered into a...


09 Nov, 2017, 01:00 GMT United States Food and Drug Administration (USFDA) - BioResearch Monitoring Program (BIMO) Conducted Two Inspections at Veeda CR - Ahmedabad

Veeda CR is glad to share the successful completion of 2 USFDA Inspections at two of its locations at Ahmedabad in Sep-2017. Both the Inspections...


08 Nov, 2017, 15:40 GMT Significant Cost Reduction in COPD Care With Simple, Drug-free Device

Aerobika* device proves to be a cost-effective treatment option in the management of post-exacerbation COPD patients. The Aerobika* device...


08 Nov, 2017, 14:21 GMT Tepha Inc. Announces Regenerative Medicine Recent Developments and R & D Initiatives

Tepha Inc., a developer and marketer of implantable medical devices based on its proprietary P4HB™ resorbable polymer technology, announced today...


08 Nov, 2017, 12:11 GMT New Clinical Data and Insurance Coverage Support Mederi's Stretta Therapy for GERD

RCT shows Stretta wins over PPI, and new coverage policy issued by Capital Blue Cross in PA Mederi is pleased to announce publication of a...


08 Nov, 2017, 09:16 GMT Novartis Launches Joint Working Project with the Royal Marsden Partners Cancer Vanguard to Improve Quality of Care and Increase Satisfaction Among Cancer Patients

- First pilot of a new cancer care model which leverages the role of the pharmacist by the Vanguard New Models of Care Programme -...


08 Nov, 2017, 08:50 GMT Cantargia Publishes Interim Report for Third Quarter of 2017

Cantargia AB's ("Cantargia") interim report for the third quarter of 2017 is now available on the company's web page...


08 Nov, 2017, 08:07 GMT Nordic Nanovector: Protocol Amendment Filed in the UK to Enable Initiation of Phase 2 PARADIGME

Nordic Nanovector ASA (OSE: NANO) notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the...


07 Nov, 2017, 13:17 GMT Results From Alligator Bioscience's Clinical Phase I Study Support Further Clinical Development of ADC-1013

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


07 Nov, 2017, 09:00 GMT Global Experts Call for Action on Vaccination Apathy, and More Protection for Older Adults Against Infectious Diseases

- 'Vaccination apathy' is a key barrier to protecting the community against infectious disease, according to global health experts...


07 Nov, 2017, 09:00 GMT MyMeds&Me Appoints Experienced Healthtech and Pharma Entrepreneur as a Non-Executive Director

Appointment of Tim Davis will help the company enhance its Reportum® service and drive its commercial growth MyMeds&Me, the leading SaaS...


07 Nov, 2017, 09:00 GMT Merck's Consumer Health Leads Debate on Preparing Gen Z for 100 Healthy Years

- New whitepaper from Consumer Health business shines light on preparing the young generation for living 100 healthy years -...